LEP and type 2 diabetes mellitus: A recent meta-analysis in patients with T2DM demonstrated that SGLT2 inhibition was associated with decreased circulating leptin (121), and we recently found that SGLT2 inhibition decreases plasma leptin in HAF rats (97).